MGNI insider sold 130,828 shares in June; 14,518-share RSU sale planned
Rhea-AI Filing Summary
Magnite, Inc. (MGNI) Form 144 filing reports proposed and recent insider sales. An insider plans to sell 14,518 common shares via Morgan Stanley on or about 08/18/2025; those shares were acquired as restricted stock units on 08/15/2025 and will be settled as equity compensation. The filing also discloses four prior sales by the same person in June 2025 totaling 130,828 shares for aggregate gross proceeds of $2,652,320.70. The issuer’s total shares outstanding listed is 142,399,305, so the proposed sale represents a small fraction of outstanding stock. The filer certifies no undisclosed material adverse information is known.
Positive
- None.
Negative
- Insider sold 130,828 shares in June 2025 across four transactions, which may be perceived negatively by some investors even though proceeds appear to be from routine sales ($2,652,320.70 total).
- Proposed sale of recently acquired RSUs (14,518 shares) suggests immediate disposition upon vesting rather than long-term holding, which some market participants may view unfavorably.
Insights
TL;DR: Insider selling is notable but represents a small percentage of shares outstanding; likely routine liquidity from compensation.
The filing shows a proposed sale of 14,518 shares acquired as restricted stock units and multiple June 2025 dispositions totaling 130,828 shares. Combined June gross proceeds of prior sales were $2,652,320.70. Relative to the reported 142.4 million shares outstanding, these transactions are immaterial to market capitalization. This pattern is consistent with post-vesting disposition of equity compensation and scheduled sales rather than a company-specific disclosure of weakness. Market impact should be limited absent other material information.
TL;DR: Disclosure complies with Rule 144; filings show standard insider reporting and a representation about material info.
The notice properly identifies the broker (Morgan Stanley Smith Barney LLC), the acquisition type (Restricted Stock Unit), and that the transaction arises from equity compensation. The signer affirms they are unaware of undisclosed material adverse information, consistent with Form 144 attestations. Governance-wise, the filing raises routine transparency points but no governance red flags are evident from the provided content alone.